AIRS
Airsculpt Technologies, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$1.67
+15.97%Year over year
Reported trailing growth
- Revenue
- -8.7%
- EBITDA
- -20.1%
- EBIT
- -36.8%
- EPS
- +25.9%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +2.2%
- EBITDA
- +262.3%
- EPS
- +69.7%
Three-year CAGR
- Revenue
- -3.5%
- EBITDA
- -35.7%
- EBIT
- —
- Net income
- -41.4%
- EPS
- -35.7%
- Free cash flow
- -60.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026